It’s a wrap!
The big day may have come and gone, but keep in touch as we’re always up to something new and exciting.
2025 Advancing Drug Development Forum Agenda
Thursday, December 11, 2025
Timing is approximate, and subject to change
Keynote Conversation
Interviewer - Alok Tayi, CEO Vibe Bio and Host of BioTech 2050
Harvey Berger, Kojin Therapeutics
Overcoming the Pitfalls of Getting Prepared for a Clinical Trial...
BREAK
Supplies issue from China to Canada
AI Applications
Sponsored by
Keith Parent, Court Square Group
Pam Wertalik, CDMO World
Alok Tayi, Vibe Bio and Host of BioTech 2050
Kevin Bittorf, SCxCMC
Networking Lunch
RNA-Targeted Small Molecules (RSMs) is Pushing the Boundaries of Drug Devel
Jennifer Petter, Arrakis Therapeutics
Far East Inlicensing: The New Research Powerhouse?
BREAK
Investments in Your Company Based on the Current Political Climate
Sponsored by
Danielle O'Neal, Banc of California
Meg Krench, Sanofi Ventures
Chris Garabedian, Perceptive Advisors
Kirk Taylor, Mass Life Science
Scaling Up Without Falling Apart: Can Culture Keep Up With Growth?
Moving from Biotech Startup to Operational Excellence
Sponsored by
Catherine Smith, The Termeer Foundation
Justin Klee, Amylyx Pharmaceuticals
Nele Van Dessel, Ernest Pharmaceuticals
Margaret "Missy" Fulton, Chameleon Strategies, LLC
Fireside Chat
Brad Loncar, BiotechTV
Joshua Cohen, Amylyx Pharmaceuticals
Ivana Magovcevic - Liebisch, PhD, JD, Vigil Neuroscience
Networking
Beyond Rule of 5 - To Be Announced Soon
Add a description about this category
Intro Round Table - Pros and Cons of Rule of 5
Add a description about this item
Round Table of Enabling Beyond Rule of 5 Advanced Technologies for Developm
Add a description about this item
Hands-On Solution Session: Solving your toughest problems
Add a description about this item
Contact Us
Have any questions?
For any inquiries on the presentations or partnerships, please contact us!
Advancing Drug Development Forum
